Global Point of Care Lipid Test Market Insights, Forecast to 2028

Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period.
Furthermore, continuous efforts by the government to reduce hospital stays and curb healthcare expenditure, establishments attempting to provide effective and rapid diagnostic results, and improvement in technology with the provision of cheap and high-quality medical solutions aimed at achieving lab automation are some factors contributing to the growth of the PoC Lipid Test market.
Market Analysis and Insights: Global Point of Care Lipid Test Market
The global Point of Care Lipid Test market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, PoC Lipid Test Instrument accounting for % of the Point of Care Lipid Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hyperlipidemia segment is altered to an % CAGR throughout this forecast period.
China Point of Care Lipid Test market size is valued at US$ million in 2021, while the North America and Europe Point of Care Lipid Test are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Point of Care Lipid Test landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Point of Care Lipid Test market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Point of Care Lipid Test market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Point of Care Lipid Test market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Point of Care Lipid Test market.
Global Point of Care Lipid Test Scope and Market Size
Point of Care Lipid Test market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Point of Care Lipid Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
PoC Lipid Test Instrument
PoC Lipid Test Consumables
Segment by Application
Hyperlipidemia
Hypertriglyceridemia
Familial Hypercholesterolemia
Hyperlipoproteinemia
Tangier Disease
Others
By Company
Abaxis Inc.
Roche Diagnostics
Alere Inc.
Polymer Technology Systems
Samsung Electronics Corporation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA